FDA accepted Cogent's application for advanced systemic mastocytosis; target FDA action dates for GIST and non-advanced mastocytosis are Nov. 30 and Dec. 30.
LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- BlackLine, Inc (Nasdaq: BL), today announced financial results for the third quarter ended September 30, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results